APA (7th ed.) Citation

Stark, F. C., Akache, B., Deschatelets, L., Tran, A., Stuible, M., Durocher, Y., . . . Handfield, M. (2022). Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters. Scientific Reports, 12(1), 1. https://doi.org/10.1038/s41598-022-13819-5

Chicago Style (17th ed.) Citation

Stark, Felicity C., et al. "Intranasal Immunization with a Proteosome-adjuvanted SARS-CoV-2 Spike Protein-based Vaccine Is Immunogenic and Efficacious in Mice and Hamsters." Scientific Reports 12, no. 1 (2022): 1. https://doi.org/10.1038/s41598-022-13819-5.

MLA (9th ed.) Citation

Stark, Felicity C., et al. "Intranasal Immunization with a Proteosome-adjuvanted SARS-CoV-2 Spike Protein-based Vaccine Is Immunogenic and Efficacious in Mice and Hamsters." Scientific Reports, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1038/s41598-022-13819-5.